IMPULSIVE-COMPULSIVE DISORDERS IN PATIENTS WITH PARKINSON'S DISEASE ON THE BACKGROUND OF CHRONIC STIMULATION OF DEEP SUBCORTICAL STRUCTURES


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The most effective drugs used in the treatment of Parkinson’s disease (PD), levodopa and dopamine receptor agonists, can lead to the development of impulsive-compulsive disorders (ICDs). Neurostimulation (NS) conducted to patients with complications of pharmacotherapy that are resistant to correction, has a dual effect on ICDs. On the one hand, the NS allows reducing the dose of prescribed dopaminergic drugs, which can reduce the severity of behavioral disorders in the postoperative period. On the other hand, there are several data on the increase or even occurrence of ICDs after surgery. This literature review considers various effects of the NS of subthalamic nucleus on ICDs in patients with PD.

Full Text

Restricted Access

About the authors

S. M Omarova

FSBEI FPE RMACPE of RMH; Center for Extrapyramidal Diseases

Email: omarova_sm@mail.ru
postgraduate student at the Department of Neurology Moscow

N. V Fedorova

FSBEI FPE RMACPE of RMH; Center for Extrapyramidal Diseases

Moscow

E. V Bril

Federal Neurological Center FMBC n.a. A.I. Burnazyan of the FMBA of Russia

Moscow

A. A Tomskiy

Functional Neurosurgery Unit FSAI National Scientific and Practical Center for Neurosurgery n.a. Academician N. N. Burdenko of RMH

Moscow

References

  1. Weintraub, D., Koester, J., Potenza, M., Siderowf, A., Stacy, M., Voon, V., Whetteckey, J., Wunderlich, G., Lang, A. Impulse Control Disorders in Parkinson Disease. Arch. Neurol. 2010;67(5):589-95.
  2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV-TR). Washington, DC: American Psychiatric Publishing, 2000.
  3. Evans A., Lees A. Dopamine dysregulation syndrome in Parkinson's disease. Curr. Opin. Neurol. 2004;17(4):393-98.
  4. Giovannoni G. Hedonistic homeostatic dysregulation in patients with Parkinson’s disease on dopamine replacement therapies. J. Neurol., Neurosurg. & Psychiatry. 2000;68(4):423-28.
  5. Voon V. Repetition, repetition, and repetition: Compulsive and punding behaviors in Parkinson’s disease. Movement Disord. 2004; 19(4):367-70.
  6. Weintraub D., Siderowf A., Potenza M., Goveas J., Morales K., Duda J., Moberg P, Stern M. Association of Dopamine Agonist Use With Impulse Control Disorders in Parkinson Disease. Arch. Neurol. 2006;63(7):969.
  7. Fan W., Ding H., Ma J., Chan P. Impulse control disorders in Parkinson’s disease in a Chinese population. Neuroscience Letters. 2009;465(1):6-9.
  8. Никитина А.А., Федорова Н.В. Импульсивно-компульсвиный синдром при болезни Паркинсона. Журн. неврол. и психиатр. им. Корсакова. 2013;7(3):32-38.
  9. O’Sullivan S., Evans A., Lees A. Dopamine dysregulation syndrome: an overview of its epidemiology, mechanisms and management. CNS Drugs. 2009;23:157-70.
  10. Evans A., Katzenschlager R., Paviour D., O’Sullivan J., Appel S., Lawrence A., Lees A. Punding in Parkinson 's disease: its relation to the dopamine dysregulation syndrome. Movement Disord. 2004;19(4):397-405.
  11. Evans A., Strafella A., Weintraub D., Stacy M. Impulsive and compulsive behaviors in Parkinson's disease. Movement Disord. 2009;24(11):1561-70.
  12. Schrag A., Trimble M. Poetic talent unmasked by treatment of Parkinson’s disease. Movement Disord. 2001;16:1175-76.
  13. Бриль Е.В., Томский А.А, Гамалея А.А., Поддубская А.А., Федорова Н.В., Губарева Н.Н., Декопов А.В., Шабалов В.А. Медикаментозная терапия на фоне электростимуляции субталамического ядра у больных болезнью Паркинсона. Журн. неврол. и психиатр. им. Корсакова 2015;6(115):73-7.
  14. Parent A., Hazrati L. Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidium in basal ganglia circuitry. Brain Res. Rev. 1995;20(1):128-54.
  15. Alexander G., DeLong M., Strick P. Parallel Organization of Functionally Segregated Circuits Linking Basal Ganglia and Cortex. Ann. Rev. Neurosci. 1986;9(1):357-81.
  16. Mallet L., Schupbach M., N'Diaye K., Remy P., Bardinet E., Czernecki V., Welter M., Pelissolo A., Ruberg M., Agid Y., Yelnik J. Stimulation of subterritories of the subthalamic nucleus reveals its role in the integration of the emotional and motor aspects of behavior. Proceedings National Acad. Sci. 2007;104(25):10661-66.
  17. Mallet L., Mesnage V., Houeto J., Pelissolo A., Yelnik J., Behar C., Gargiulo M., Welter M., Bonnet A., Pillon B., Cornu P., Dormont D., Pidoux B., Allilaire J., Agid Y. Compulsions, Parkinson's disease, and stimulation. Lancet. 2002;360(9342):1302-304.
  18. Follett K., Weaver F., Stern M., Hur K., Harris C., Luo P., Marks W., Rothlind, J., Sagher O., Moy C., Pahwa R., Burchiel K., Hogarth P., Lai E., Duda J., Holloway K., Samii A., Horn S., Bronstein J., Stoner G., Starr P., Simpson R., Baltuch G., De Salles A., Huang G., Reda D. Pallidal versus Subthalamic Deep-Brain Stimulation for Parkinson's Disease. N. Engl. J. Med. 2010;362(22):2077-91.
  19. Castrioto A., Volkmann J., Krack P. Postoperative management of deep brain stimulation in Parkinson's disease. Handbook Clin. Neurol. 2013;116:129-46.
  20. Volkmann J., Daniels C., Witt K. Neuropsychiatric effects of subthalamic neurostimulation in Parkinson disease. Nature Rev. Neurol. 2010;6:487-98.
  21. Voon V., Krack P., Lang A., Lozano A., Dujardin K., Schupbach M.,D'Ambrosia J.,Thobois S., Tamma F., Herzog J., Speelman J., Samanta J., Kubu C., Rossignol H., Poon Y., Saint-Cyr J., Ardouin C., Moro E. A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease. Brain. 2008;131(10):2720-28.
  22. Zahodne L., Susatia F., Bowers D., Ong T., Jacobson C., Okun M., Rodriguez R., Malaty I., Foote K., Fernandez, H. Binge Eating in Parkinson's Disease: Prevalence, Correlates and the Contribution of Deep Brain Stimulation. J. Neuropsychiatry. 2011;23(1):56-62.
  23. Contarino M., Daniele A., Sibilia A., Romito L., Bentivoglio A., Gainotti G., Albanese, A. Cognitive outcome 5 years after bilateral chronic stimulation of subthalamic nucleus in patients with Parkinson's disease. J. Neurol., Neurosurg. & Psychiatry. 2006;78(3):248-52.
  24. Eusebio A., Witjas T., Cohen, J., Fluchere F., Jouve E., Regis J., Azulay J. Subthalamic nucleus stimulation and compulsive use of dopaminergic medication in Parkinson's disease. J. Neurol., Neurosurg. & Psychiatry. 2013;84(8):868-74.
  25. Amami P., Dekker I., Piacentini S., Ferr F., Romito L., Franzini A., Foncke E., Albanese A. Impulse control behaviours in patients with Parkinson's disease after subthalamic deep brain stimulation: de novo cases and 3-year follow-up. J. Neurol., Neurosurg. & Psychiatry. 2014;86(5):562-64.
  26. Hälbig T., Tse W., Frisina P., Baker B., Hollander E., Shapiro H., Tagliati M., Koller W., Olanow C. Subthalamic deep brain stimulation and impulse control in Parkinson's disease. Eur. J. Neurol. 2009;16(4):493-97.
  27. Kim Y, Kim H., Kim H., Lee J., Yun J., Kim J., Paek S., Jeon B. Impulse control and related behaviors after bilateral subthalamic stimulation in patients with Parkinson's disease. J. Clin. Neurosci. 2013;20(7):964-69.
  28. Kleiner-Fisman G., Fisman D., Sime E., Saint-Cyr J., Lozano A., Lang, A. Long-term follow up of bilateral deep brain stimulation of the subthalamic nucleus in patients with advanced Parkinson disease. J. Neurosurgery. 2003;99(3):489-95.
  29. Lu C., Bharmal A., Suchowersky O. Gambling and Parkinson Disease. Arch. Neurol. 2006;63(2):298.
  30. Smeding H., Speelman J., Koning-Haanstra M., Schuurman P, Nijssen P., van Laar T., Schmand B. Neuropsychological effects of bilateral STN stimulation in Parkinson disease: A controlled study Neurology 2006;66(12):1830-36.
  31. Doshi P., Bhargava P. Hypersexuality following subthalamic nucleus stimulation for Parkinson's disease. Neurology India. 2008;56(4):474-76.
  32. Funkiewiez A. Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson's disease. J. Neurol., Neurosurg. & Psychiatry. 2004;75(6):834-39.
  33. Umemura A., Oka Y., Yamamoto K., Okita K., Matsukawa N., Yamada K. Complications of Subthalamic Nucleus Stimulation in Parkinson's Disease. Neurologia medico-chirurgica. 2011;51(11):749-55.
  34. Vidailhet M., Vercueil L., Houeto J., Krystkowiak P., Lagrange C., Yelnik J., Bardinet E., Benabid A., Navarro S., Dormont D., Grand S., Blond S., Ardouin C., Pillon B., Dujardin K., Hahn-Barma V., Agid Y., Destée A., Pollak P. Bilateral, pallidal, deep-brain stimulation in primary generalised dystonia: a prospective 3 year follow-up study. Lancet Neurology. 2007;6(3):223-29.
  35. Romito L., Scerrati M., Contarino M., Bentivoglio A., Tonali P., Albanese A. Long-term follow up of subthalamic nucleus stimulation in Parkinson's disease. Neurology. 2002;58(10):1546-50.
  36. Lim S., O'Sullivan S., Kotschet K., Gallagher D., Lacey C., Lawrence A., Lees A., O'Sullivan D., Peppard R., Rodrigues J., Schrag A., Silberstein P., Tisch S. and Evans, A. Dopamine dysregulation syndrome, impulse control disorders and punding after deep brain stimulation surgery for Parkinson's disease. J. Clin. Neurosci. 2009;16(9):1148-52.
  37. Bandini F., Primavera A., Pizzorno M., Cocito L. Using STN DBS and medication reduction as a strategy to treat pathological gambling in Parkinson's disease. Parkinsonism & Related Disord. 2007;13(6):369-71.
  38. Poletti M., Perugi G., Logi C., Romano A., Del Dotto P., Ceravolo R., Rossi G., Pepe P., Dell'Osso L., Bonuccelli U. Dopamine agonists and delusional jealousy in Parkinson's disease: A cross-sectional prevalence study. Movement Disord. 2012;27(13):1679-82.
  39. Joutsa J., Martikainen K., Niemel S., Johansson J., Forsback S., Rinne J., Kaasinen V. Increased medial orbitofrontal [18F]fluorodopa uptake in Parkinsonian impulse control disorders. Movement Disord. 2012;27(6):778-82.
  40. Evans A., Kettlewell J., McGregor S., Kotschet K., Griffiths R.,Horne M. A Conditioned Response as a Measure of Impulsive-Compulsive Behaviours in Parkinson's Disease. PLoS ONE. 2014;9(2):e89319.
  41. Bernath S., Zigmond M. Dopamine may influence striatal GABA release via three separate mechanisms. Brain Research. 1989;476(2):373-76.
  42. Zigmond M., Abercrombie E., Berger T., Grace A., Stricker E. Compensations after lesions of central dopaminergic neurons: some clinical and basic implications. Trends Neurosci. 1990;13(7):290-96.
  43. Kim J., Kim H., Lee J., Kim J., Yun J., Jeon B. Hypomania Induced by Subthalamic Nucleus Stimulation in a Parkinson's Disease Patient: Does It Suggest a Dysfunction of the Limbic Circuit? J. Movement Disord. 2012;5(1):14-7.
  44. Kalivas P. The glutamate homeostasis hypothesis of addiction. Nature Rev. Neurosci. 2009;10(8):561-72.
  45. Hoerst M., Weber-Fahr W., Tunc-Skarka N., Ruf M., Bohus M., Schmahl C., Ende G. Correlation of Glutamate Levels in the Anterior Cingulate Cortex With Self-reported Impulsivity in Patients With Borderline Personality Disorder and Healthy Controls. Arch. General Psychiatry. 2010;67(9):946.
  46. Lovallo W. Cortisol secretion patterns in addiction and addiction risk. Intern. J. Psychophysiol. 2006;59(3):195-202.
  47. Black D., Moyer T. Clinical Features and Psychiatric Comorbidity of Subjects With Pathological Gambling Behavior. Psychiatric Services. 1998;49(11):1434-39.
  48. Slutske W., Zhu G., Meier M., Martin N. Disordered gambling as defined by the Diagnostic and Statistical Manual of Mental Disorders and the South Oaks Gambling Screen: Evidence for a common etiologic structure. J. Abnormal Psychol. 2011; 120(3):743-51.
  49. Comings D., Gade-Andavolu R., Gonzalez N., Wu S., Muhleman D., Chen C., Koh P., Farwell K., Blake H., Dietz G., MacMurray J., Lesieur H., Rugle L., Rosenthal R. The additive effect of neurotransmitter genes in pathological gambling. Clinical Genetics. 2008;60(2):107-116.
  50. Temel Y., Kessels A., Tan S., Topdag A., Boon P., Visser-Vandewalle V. Behavioural changes after bilateral subthalamic stimulation in advanced Parkinson disease: A systematic review. Parkinsonism & Related Disord. 2006;12(5):265-72.
  51. Sensi M., Eleopra R., Cavallo M., Sette E., Milani P., Quatrale R., Capone J., Tugnoli V., Tola M., Granieri E., Data P. Explosive-aggressive behavior related to bilateral subthalamic stimulation. Parkinsonism & Related Disord. 2004;10(4):247-51.
  52. Benarroch E. Subthalamic nucleus and its connections: Anatomic substrate for the network effects of deep brain stimulation. Neurology. 2008;70(21):1991-95.
  53. Djamshidian A., Averbeck B., Lees A., O'Sullivan S. Clinical aspects of impulsive compulsive behaviours in Parkinson's disease. J. Neurol. Sci. 2011;310(1-2):183-88.
  54. Alexander G., Crutcher M. Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci. 1990;13(7):266-71.
  55. Witjas T., Baunez C., Henry J., Delfini M., Regis J., Cherif A., Peragut J., Azulay J. Addiction in Parkinson's disease: Impact of subthalamic nucleus deep brain stimulation. Movement Disord. 2005;20(8):1052-55.
  56. Voon V., Fernagut P., Wickens J., Baunez C., Rodriguez M., Pavon N., Juncos J., Obeso J., Bezard E. Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders. Lancet Neurology. 2009;8(12):1140-49.
  57. Thobois S., Ardouin C., Lhommee E., Klinger H., Lagrange C., Xie J., Fraix V., Coelho Braga M., Hassani R., Kistner A., Juphard A., Seigneuret E., Chabardes S., Mertens P., Polo G., Reilhac A., Costes N., LeBars D., Savasta M., Tremblay L., Quesada J., Bosson J., Benabid A., Broussolle E., Pollak P., Krack P. Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation. Brain. 2010;133(4):1111-27.
  58. Houeto J., Mallet L., Mesnage V., Tezenas du Montcel S., Béhar C., Gargiulo M., Torny F., Pelissolo A., Welter M., Agid Y. Subthalamic Stimulation in Parkinson Disease. Arch. Neurol. 2006;63(8):1090.
  59. Mikos A., Bowers D., Noecker A., McIntyre C., Won M., Chaturvedi A., Foote K. and Okun M. Patient-specific analysis of the relationship between the volume of tissue activated during DBS and verbal fluency. NeuroImage. 2011;54:238-S246.
  60. Le Jeune F., Péron J., Grandjean D., Drapier S., Haegelen C., Garin E., Millet B., Vérin M. Subthalamic nucleus stimulation affects limbic and associative circuits: a PET study. Eur. J. Nuclear Medicine Molecular Imaging. 2010;37(8):1512-20.
  61. Limousin P., Greene J., Pollak P., Rothwell J., Benabid A., Frackowiak R. Changes in cerebral activity pattern due to subthalamic nucleus or internal pallidum stimulation in Parkinson's disease. Ann. Neurol. 1997;42(3):283-91.
  62. Lhommee E., Klinger H., Thobois S., Schmitt E., Ardouin C., Bichon A., Kistner A., Fraix V., Xie J., Aya Kombo M., Chabardes S., Seigneuret E., Benabid A., Mertens P., Polo G., Carnicella S., Quesada J., Bosson J., Broussolle E., Pollak P., Krack P. Subthalamic stimulation in Parkinson's disease: restoring the balance of motivated behaviours. Brain. 2012; 135(5):1463-77.
  63. Knobel D., Aybek S., Pollo C., Vingerhoets F., Berney A. Rapid Resolution of Dopamine Dysregulation Syndrome (DDS) After Subthalamic DBS for Parkinson Disease (PD). Cognitive Behavioral Neurol. 2008; 21(3):187-89.
  64. Smeding H., Goudriaan A., Foncke E., Schuurman P., Speelman J., Schmand B. Pathological gambling after bilateral subthalamic nucleus stimulation in Parkinson disease. J. Neurol., Neurosurg. & Psychiatry. 2006;78(5):517-19.
  65. Houeto J. Behavioural disorders, Parkinson's disease and subthalamic stimulation. J. Neurol., Neurosurg. & Psychiatry. 2002;72(6):701-7.
  66. Schupbach W. Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up. J. Neurol., Neurosurg. & Psychiatry. 2005;76(12):1640-44.
  67. De la Casa-Fages B., Grandas F Dopamine dysregulation syndrome after deep brain stimulation of the subthalamic nucleus in Parkinson's disease. J. Neurol. Sci. 2012; 312(1-2):191-93.
  68. Weintraub D., Hoops S., Shea J., Lyons K., Pahwa R., Driver-Dunckley E., Adler C., Potenza M., Miyasaki J., Siderowf A., Duda J., Hurtig H., Colcher A., Horn S., Stern M., Voon V. Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease. Movement Disord. 2009;24(10):1461-67.
  69. Plutchik R., Van Praag H. The measurement of suicidality, aggressivity and impulsivity. Progress in Neuro-Psychopharmacol. Biol. Psychiatry. 1989;13:S23-S34.
  70. Kimber T., Thompson P., Kiley M. Resolution of dopamine dysregulation syndrome following cessation of dopamine agonist therapy in Parkinson's disease. J. Clin. Neurosci. 2008;15(2):205-8.
  71. Mamikonyan E., Siderowf A., Duda J., Potenza M., Horn S., Stern M., Weintraub D. Long-term follow-up of impulse control disorders in Parkinson's disease. Movement Disord. 2008;23(1):75-80.
  72. Sohtaoglu M., Demiray D., Kenangil G., Özekmekci S., Erginöz E. Long term follow-up of Parkinson's disease patients with impulse control disorders. Parkinsonism & Related Disord. 2010;16(5):334-37.
  73. Black D., Moyer T. Clinical Features and Psychiatric Comorbidity of Subjects With Pathological Gambling Behavior. Psychiatric Services. 1998;49(11):1434-39.
  74. Nirenberg M. Dopamine agonist withdrawal syndrome and non-motor symptoms after Parkinson's disease surgery. Brain. 2010;133(11):e155-e155.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2017 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies